Ok Biotech Co Ltd
OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring systems and homecare healthcare devices in Taiwan and internationally. It also offers OTC hearing aids, multi-frequency therapy devices, and factory setup solutions. The company was founded in 2004 and is based in Hsinchu City, Taiwan.
Market Cap & Net Worth: Ok Biotech Co Ltd (4155)
Ok Biotech Co Ltd (TW:4155) has a market capitalization of $59.22 Million (NT$1.96 Billion) as of March 19, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #21769 globally and #1216 in its home market, demonstrating a -2.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ok Biotech Co Ltd's stock price NT$13.60 by its total outstanding shares 144059164 (144.06 Million).
Ok Biotech Co Ltd Market Cap History: 2015 to 2026
Ok Biotech Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $89.49 Million to $59.22 Million (-0.89% CAGR).
Ok Biotech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ok Biotech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Ok Biotech Co Ltd's market cap is 0.05 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.95x
Ok Biotech Co Ltd's market cap is 0.95 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $89.49 Million | $856.55 Million | $110.97 Million | 0.10x | 0.81x |
| 2016 | $79.52 Million | $1.04 Billion | $85.20 Million | 0.08x | 0.93x |
| 2017 | $86.83 Million | $1.23 Billion | $126.81 Million | 0.07x | 0.68x |
| 2018 | $74.69 Million | $1.12 Billion | $161.36 Million | 0.07x | 0.46x |
| 2019 | $108.61 Million | $1.24 Billion | $125.76 Million | 0.09x | 0.86x |
| 2020 | $91.55 Million | $1.48 Billion | $129.73 Million | 0.06x | 0.71x |
| 2021 | $83.70 Million | $1.26 Billion | $31.42 Million | 0.07x | 2.66x |
| 2022 | $103.08 Million | $1.48 Billion | $143.46 Million | 0.07x | 0.72x |
| 2023 | $107.93 Million | $1.19 Billion | $2.95 Million | 0.09x | 36.61x |
| 2024 | $89.04 Million | $1.67 Billion | $93.97 Million | 0.05x | 0.95x |
Competitor Companies of 4155 by Market Capitalization
Companies near Ok Biotech Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Ok Biotech Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Ok Biotech Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Ok Biotech Co Ltd's market cap moved from $89.49 Million to $ 59.22 Million, with a yearly change of -0.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$59.22 Million | -6.21% |
| 2025 | NT$63.13 Million | -29.10% |
| 2024 | NT$89.04 Million | -17.51% |
| 2023 | NT$107.93 Million | +4.70% |
| 2022 | NT$103.08 Million | +23.16% |
| 2021 | NT$83.70 Million | -8.58% |
| 2020 | NT$91.55 Million | -15.71% |
| 2019 | NT$108.61 Million | +45.41% |
| 2018 | NT$74.69 Million | -13.98% |
| 2017 | NT$86.83 Million | +9.19% |
| 2016 | NT$79.52 Million | -11.14% |
| 2015 | NT$89.49 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ok Biotech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $59.22 Million USD |
| MoneyControl | $59.22 Million USD |
| MarketWatch | $59.22 Million USD |
| marketcap.company | $59.22 Million USD |
| Reuters | $59.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.